Peer-influenced content. Sources you trust. No registration required. This is HCN.
Multiple Sclerosis News Today
Among newly diagnosed, treatment-naive patients with multiple sclerosis, gut microbiome profiles differed from healthy controls and were associated with MRI features linked to poorer prognosis, suggesting a potential future role for microbiome-based risk stratification.
Family Medicine/General Practice October 6th 2026
An experimental cell therapy that couples a patient’s red blood cells with myelin protein fragments was well tolerated in a 10-patient Phase 1b study and was associated with increases in regulatory T-cells and reductions in neurofilament light chain, a biomarker linked to nerve injury.
Neuroimmunology September 9th 2026
MDLinx
Differences in cerebrospinal fluid proteins distinguished women with multiple sclerosis from age-matched controls in a small exploratory study, highlighting potential hormonal and immune-related biological mechanisms. Findings require validation in larger populations before clinical application.
Internal Medicine July 15th 2026
Neurology Advisor
Persistent EBV antibody elevations distinguished MS from MOGAD and NMOSD when tracked over time in a large multicenter cohort.
Internal Medicine April 15th 2026